DAWN GIESE: Open Payments
NPI 1679050108 · REED CITY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$658 in 29 payments from 14 companies in 2025. Trend: 2023 $343 · 2024 $826 · 2025 $658
Food & beverage: $658
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $144 |
| PFIZER INC. | 4 | $80 |
| Exact Sciences Corporation | 3 | $61 |
| Supernus Pharmaceuticals, Inc. | 2 | $57 |
| ABBVIE INC. | 3 | $54 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $46 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| Astellas Pharma US Inc | 2 | $38 |
| Abbott Laboratories | 2 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $28 |
Products named: AIRSUPRA, Cologuard Collection Kit, NURTEC ODT, Qelbree, JOURNAVX, REXULTI, UBRELVY, Veozah.
Industry payments across MI — which companies pay providers there.
